HOOKIPA Pharma News

Buy Rating Affirmed for Hookipa Pharma Amid Positive HB-200 Vaccine Trials and Robust Financial Position

TipRanksMay 24 13:55

Royal Bank of Canada: The HOOKIPA Pharma (HOOK.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $5.00.

Zhitong FinanceMay 21 12:10

HOOKIPA Pharma Analyst Ratings

BenzingaMay 21 12:09

Analysts Are Bullish on Top Healthcare Stocks: Hookipa Pharma (HOOK), Chemed (CHE)

TipRanksMay 21 06:01

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)

TipRanksMay 14 03:40

RBC Capital Initiates a Buy Rating on Hookipa Pharma (HOOK)

TipRanksMay 10 05:41

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)

TipRanksMay 9 11:40

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)

TipRanksApr 30 01:12

HC Wainwright & Co. Maintains Buy on HOOKIPA Pharma, Lowers Price Target to $5

BenzingaApr 26 05:55

HOOKIPA Pharma Analyst Ratings

BenzingaApr 26 05:52

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)

TipRanksApr 26 05:20

Buy Rating Affirmed for Hookipa Pharma Amidst Promising Pipeline and Strategic Advancements

TipRanksApr 24 13:45

Optimistic Buy Rating for Hookipa Pharma Based on Promising HB-200 Trial Results and Strategic Trial Design

TipRanksMar 27 01:56

Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Hookipa Pharma (HOOK) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksMar 25 05:30

HOOKIPA Pharma Analyst Ratings

BenzingaMar 25 05:23

Hookipa Pharma (HOOK) Receives a Buy From RBC Capital

TipRanksMar 24 20:48

Buy Rating Affirmed for Hookipa Pharma on Emerging Oncology and Infectious Disease Pipelines

TipRanksMar 22 10:55

Maintaining Buy Rating on Hookipa Pharma Amid Strategic Repositioning and Pipeline Promise

TipRanksJan 31 23:07

HOOKIPA Pharma Analyst Ratings

BenzingaJan 30 09:12

RBC Cuts Price Target on HOOKIPA Pharma to $5 From $6 Amid Restructuring Plan, Termination of Roche Partnership on KRAS; Outperform, Speculative Risk Kept

MT NewswiresJan 30 06:20